CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale Director sold 1,000 shares at $72.13 ($72,130)
- 4 Planned sale President & CEO sold 105,426 shares at an average $69.62 ($7,340,010)
- 4 Planned sale Director sold 1,000 shares at $74.66 ($74,660)
- 144 Insider Sale of Securities
- 4 Planned sale EVP Research & Development sold 3,500 shares at $75.46 ($264,110)
- 4 Planned sale Director sold 5,000 shares at $71.48 ($357,400)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, Chief Commercial Officer sold 10,000 shares at $70.24 ($702,400)
- 4 Planned sale President & CEO sold 7,500 shares at $70.24 ($526,800)
- 8-K Event Other events
- 4 Planned sale EVP Research & Development sold 3,500 shares at $75.82 ($265,370)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Planned sale President & CEO sold 7,500 shares at $76.76 ($575,700)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale EVP, Chief Commercial Officer sold 14,000 shares at $79.88 ($1,118,320)
- 144 Insider Sale of Securities
- 4 Planned sale President & CEO sold 7,500 shares at $80.87 ($606,525)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $80.59 ($282,065)
Page 2 of 127 · 2,533 filings